RENO, Nev., Feb. 23, 2005 (PRIMEZONE) -- Martin Nutraceuticals Inc. (Pink Sheets:MTNU) is a company focused on developing natural and alternative medicine products that provide better health for individuals through the use of their wide range of products, which aid in joint therapy, digestive therapy, weight control, blood circulation and alertness, and overall improved functioning of the body.
The flagship product which is based on Joint Therapy is used to aid in joint and general arthritic pain. Over 65 million Americans suffer from arthritis and osteoporosis. For several years, Dr. A. W. Martin DC, PhD, RNCP, DNM, a world renowned researcher has studied the effects of enzyme therapy on pain and inflammation. Dr. Martin has developed a unique blend of proprietary and patented "systemic oral enzymes" designed to provide superior anti-inflammatory benefits. Studies have shown that Dr. Martin's Joint Therapy, proprietary enzyme formula reduces pain and inflammation in 80% of patients who are diagnosed with Osteoarthritis of the knees in less than 6-weeks.
In another study conducted the patient Fibromyalgia -- a severe muscle pain syndrome that affects more than 20 million North Americans -- 90% of patients reported relief from swelling and pain within 4-weeks of using Dr. Martin's Joint Therapy formula.
The nutraceuticals market has grown steadily at an incredible rate of 15-20% annually since 1998. Currently in North America, over $3.9 billion is spent on over-the-counter and prescription medication for arthritis, joint and muscle related pain alone. Since Dr. Martin's foray into the nutraceuticals market, Dr. Martin's products have amassed sales over $35 million. It is with this track record and knowledge that Martin Nutraceuticals has re-branded many of Dr. Martin's successful formulas and is poised to unveil them onto an international platform.
In the weeks and months to come, the company will be unveiling new product lines, various sales targets, contracts, distribution agreements and clinical data.
Forward Looking Statements
The management of the company, who take full responsibility for its content, prepared this press release. Statements in this news release concerning the company's business outlook or future economic performance, anticipated profitability, revenues, expenses, or other financial items; and statements concerning assumptions made or expectations as to any future events, conditions, performance or other matters, are "forward-looking statements" as that term is defined under the Federal Securities Laws. Forward-looking statements are subject to risks, uncertainties and other factors which could cause actual results to differ materially from those contained in such statements. Such risks, uncertainties and factors include, but are not limited to, future capital needs, changes and delays in product development plans and schedules, customer acceptance of new products, changes in pricing or other actions by competitors, and general economic conditions.
For more information please visit www.martinnutra.com or contact (780) 707-0587